rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jolanda Howe

SVP, Global Controller

Company insider

Files Form 4 as: SVP, Global Controller, Mirum Pharmaceuticals.

In numbers

Trades disclosed
101
Buys
0
Sells
24
Bought
$0
Sold
$14.9M
Companies
1
Companies where not an officer
0
First trade
30 Jun 2023
Last trade
16 Oct 2026
Last filed
19 Oct 2026

Companies traded

Where they are an officer
MIRM Mirum PharmaceuticalsOfficer · Biotechnology · last 16 Oct 20260 buys · 24 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Oct 2026filed 19 Oct 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Code M$310K16,112 at $19.24filing
16 Oct 2026filed 19 Oct 2026MIRM Mirum Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—16,112 at $0.00filing
2 Sep 2026filed 3 Sep 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$66K658 at $100.00filing
2 Sep 2026filed 3 Sep 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$66K658 at $100.00filing
18 Aug 2026filed 19 Aug 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Code M$251K40,000 at $6.27filing
18 Aug 2026filed 19 Aug 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$4.0M40,000 at $100.00filing
18 Aug 2026filed 19 Aug 2026MIRM Mirum Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—40,000 at $0.00filing
18 Aug 2026filed 19 Aug 2026MIRM Mirum Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—40,000 at $0.00filing
18 Aug 2026filed 19 Aug 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Code M$251K40,000 at $6.27filing
18 Aug 2026filed 19 Aug 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$4.0M40,000 at $100.00filing
3 Aug 2026filed 5 Aug 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$194K1,840 at $105.29filing
3 Aug 2026filed 5 Aug 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$194K1,840 at $105.29filing
1 Jul 2026filed 2 Jul 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$327K2,721 at $120.00filing
1 Jul 2026filed 2 Jul 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$327K2,721 at $120.00filing
17 Jun 2026filed 18 Jun 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$264K2,594 at $101.95filing
17 Jun 2026filed 18 Jun 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$264K2,594 at $101.95filing
16 Mar 2026filed 17 Mar 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$435K4,732 at $91.98filing
16 Mar 2026filed 17 Mar 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Sold$435K4,732 at $91.98filing
15 Mar 2026filed 17 Mar 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Code M—2,658filing
15 Mar 2026filed 17 Mar 2026MIRM Mirum PharmaceuticalsBiotechnologySEC FORM 4 Code M—6,000filing

News

Sectors

Health Care24

Buys in green, sells in red, by the company’s sector.

Related people

Robert Paul MyersChief Medical Officer · Chief Medical Officer at Mirum Pharmaceuticals, filing Form 4 there in the last year
Christopher PeetzChief Executive Officer · Chief Executive Officer at Mirum Pharmaceuticals, filing Form 4 there in the last year
Eric BjerkholtChief Financial Officer · Chief Financial Officer at Mirum Pharmaceuticals, filing Form 4 there in the last year
Patrick J. HeronDirector · Director at Mirum Pharmaceuticals, filing Form 4 there in the last year
Laura BregeDirector · Director at Mirum Pharmaceuticals, filing Form 4 there in the last year